Keenova Therapeutics plc - G5785G107
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | — | P | A | 410,000.0 | 90.5 | 37,105,000.0 | 5,637,714.0 | View | |
| Apr 17, 2026 | — | P | A | 275,000.0 | 88.5 | 24,337,500.0 | 5,227,714.0 | View | |
| Feb 26, 2026 | President and CEO | A | A | 198,539.0 | 0.0 | 0.0 | 506,815.0 | View | |
| Feb 26, 2026 | EVP, Chief Operations Officer | A | A | 34,528.0 | 0.0 | 0.0 | 48,913.0 | View | |
| Feb 26, 2026 | President and CFO | A | A | 101,262.0 | 0.0 | 0.0 | 174,181.0 | View | |
| Feb 26, 2026 | EVP & Chief Info Officer | A | A | 15,936.0 | 0.0 | 0.0 | 26,169.0 | View | |
| Feb 26, 2026 | EVP & CLO and Corp Sec | A | A | 51,794.0 | 0.0 | 0.0 | 97,825.0 | View | |
| Feb 26, 2026 | EVP & Chief Compliance Officer | A | A | 15,936.0 | 0.0 | 0.0 | 27,683.0 | View | |
| Feb 26, 2026 | EVP & CHRO | A | A | 34,528.0 | 0.0 | 0.0 | 48,240.0 | View | |
| Feb 26, 2026 | EVP & Chief Commercial Officer | A | A | 51,794.0 | 0.0 | 0.0 | 97,825.0 | View | |
| Feb 26, 2026 | EVP, Chief Scientific Officer | A | A | 58,434.0 | 0.0 | 0.0 | 58,434.0 | View | |
| Feb 26, 2026 | EVP & Chief Transformation OFC | A | A | 51,794.0 | 0.0 | 0.0 | 97,825.0 | View | |
| Feb 25, 2026 | — | A | A | 3,984.0 | 0.0 | 0.0 | 8,866.0 | View | |
| Feb 25, 2026 | — | A | A | 3,984.0 | 0.0 | 0.0 | 31,882.0 | View | |
| Feb 25, 2026 | — | A | A | 3,984.0 | 0.0 | 0.0 | 10,494.0 | View | |
| Feb 25, 2026 | — | A | A | 3,984.0 | 0.0 | 0.0 | 8,866.0 | View | |
| Feb 25, 2026 | — | A | A | 3,984.0 | 0.0 | 0.0 | 8,866.0 | View | |
| Feb 25, 2026 | — | A | A | 5,312.0 | 0.0 | 0.0 | 11,821.0 | View | |
| Feb 25, 2026 | — | A | A | 3,984.0 | 0.0 | 0.0 | 39,554.0 | View | |
| Feb 25, 2026 | — | A | A | 3,984.0 | 0.0 | 0.0 | 47,225.0 | View | |
| Feb 12, 2026 | — | J | A | 33,651.0 | — | — | 7,979,827.0 | View | |
| Jan 09, 2026 | — | P | A | 250,000.0 | 92.25 | 23,062,500.0 | 4,952,714.0 | View | |
| Jan 05, 2026 | — | M | D | 3,014.0 | 0.0 | 0.0 | 43,241.0 | View | |
| Jan 05, 2026 | — | D | D | 2,466.0 | — | — | 46,255.0 | View | |
| Jan 05, 2026 | — | F | D | 854.0 | — | — | 4,178.0 | View | |
| Jan 05, 2026 | — | M | A | 3,014.0 | — | — | 5,032.0 | View | |
| Jan 05, 2026 | — | M | D | 1,808.0 | 0.0 | 0.0 | 27,898.0 | View | |
| Jan 05, 2026 | — | D | D | 1,480.0 | — | — | 29,706.0 | View | |
| Jan 05, 2026 | — | F | D | 513.0 | — | — | 2,505.0 | View | |
| Jan 05, 2026 | — | M | A | 1,808.0 | — | — | 3,018.0 | View | |
| Jan 05, 2026 | EVP & Chief Commercial Officer | M | D | 6,576.0 | 0.0 | 0.0 | 46,031.0 | View | |
| Jan 05, 2026 | EVP & Chief Commercial Officer | F | D | 1,986.0 | — | — | 8,390.0 | View | |
| Jan 05, 2026 | EVP & Chief Commercial Officer | M | A | 6,576.0 | — | — | 10,376.0 | View | |
| Jan 05, 2026 | EVP & Chief Transformation OFC | M | D | 6,576.0 | 0.0 | 0.0 | 46,031.0 | View | |
| Jan 05, 2026 | EVP & Chief Transformation OFC | F | D | 2,398.0 | — | — | 7,538.0 | View | |
| Jan 05, 2026 | EVP & Chief Transformation OFC | M | A | 6,576.0 | — | — | 9,936.0 | View | |
| Jan 05, 2026 | President and CEO | M | D | 32,878.0 | 0.0 | 0.0 | 308,276.0 | View | |
| Jan 05, 2026 | President and CEO | F | D | 16,939.0 | — | — | 31,718.0 | View | |
| Jan 05, 2026 | President and CEO | M | A | 32,878.0 | — | — | 48,657.0 | View | |
| Jan 05, 2026 | EVP, Qual & Ops, Spec Brands | M | D | 2,055.0 | 0.0 | 0.0 | 14,385.0 | View | |
| Jan 05, 2026 | EVP, Qual & Ops, Spec Brands | F | D | 1,073.0 | — | — | 1,802.0 | View | |
| Jan 05, 2026 | EVP, Qual & Ops, Spec Brands | M | A | 2,055.0 | — | — | 2,875.0 | View | |
| Jan 05, 2026 | EVP & CLO and Corp Sec | M | D | 6,576.0 | 0.0 | 0.0 | 46,031.0 | View | |
| Jan 05, 2026 | EVP & CLO and Corp Sec | F | D | 2,107.0 | — | — | 8,167.0 | View | |
| Jan 05, 2026 | EVP & CLO and Corp Sec | M | A | 6,576.0 | — | — | 10,274.0 | View | |
| Jan 05, 2026 | — | M | D | 4,384.0 | 0.0 | 0.0 | 35,570.0 | View | |
| Jan 05, 2026 | — | M | A | 4,384.0 | — | — | 8,031.0 | View | |
| Dec 23, 2025 | President and CFO | F | D | 18,631.0 | — | — | 17,828.0 | View | |
| Dec 17, 2025 | President and CFO | M | D | 30,335.0 | 0.0 | 0.0 | 60,672.0 | View | |
| Dec 17, 2025 | President and CFO | M | A | 30,335.0 | — | — | 30,335.0 | View | |
| Dec 10, 2025 | — | P | A | 130,974.0 | 88.75 | 11,623,942.5 | 4,702,714.0 | View | |
| Nov 19, 2025 | — | P | A | 42,000.0 | 88.875 | 3,732,750.0 | 4,571,740.0 | View | |
| Nov 19, 2025 | — | P | A | 26,000.0 | 88.875 | 2,310,750.0 | 4,529,740.0 | View | |
| Nov 12, 2025 | — | P | A | 290,000.0 | 93.75 | 27,187,500.0 | 4,503,724.0 | View | |
| Nov 12, 2025 | EVP & Head of Spec Generics | D | A | 43,771.0 | 0.0 | 0.0 | 0.0 | View |